365 related articles for article (PubMed ID: 7551788)
1. Derivation of the optimum dose per fraction from the linear quadratic model.
Jones B; Tan LT; Dale RG
Br J Radiol; 1995 Aug; 68(812):894-902. PubMed ID: 7551788
[TBL] [Abstract][Full Text] [Related]
2. A mathematical model of intraluminal and intracavitary brachytherapy.
Jones B; Dale RG; Bleasdale C; Tan LT; Davies M
Br J Radiol; 1994 Aug; 67(800):805-12. PubMed ID: 8087488
[TBL] [Abstract][Full Text] [Related]
3. Mathematical models of tumour and normal tissue response.
Jones B; Dale RG
Acta Oncol; 1999; 38(7):883-93. PubMed ID: 10606418
[TBL] [Abstract][Full Text] [Related]
4. The influence of repopulation kinetics on isoeffect doses for permanent implants.
Kneschaurek P
Strahlenther Onkol; 1994 Oct; 170(10):602-7. PubMed ID: 7974172
[TBL] [Abstract][Full Text] [Related]
5. Estimation of optimum dose per fraction for high LET radiations: implications for proton radiotherapy.
Jones B; Dale RG
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1549-57. PubMed ID: 11121661
[TBL] [Abstract][Full Text] [Related]
6. Impact of tumor repopulation on radiotherapy planning.
Wang JZ; Li XA
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):220-7. PubMed ID: 15629615
[TBL] [Abstract][Full Text] [Related]
7. Tumour cell repopulation during fractionated radiotherapy: correlation between flow cytometric and radiobiological data in three murine tumours.
Begg AC; Hofland I; Kummermehr J
Eur J Cancer; 1991; 27(5):537-43. PubMed ID: 1828958
[TBL] [Abstract][Full Text] [Related]
8. Radiobiological assessment of permanent implants using tumour repopulation factors in the linear-quadratic model.
Dale RG
Br J Radiol; 1989 Mar; 62(735):241-4. PubMed ID: 2702381
[TBL] [Abstract][Full Text] [Related]
9. The reduction of tumour control with increasing overall time: mathematical considerations.
Jones B; Dale RG
Br J Radiol; 1996 Sep; 69(825):830-8. PubMed ID: 8983587
[TBL] [Abstract][Full Text] [Related]
10. The minimal FLASH sparing effect needed to compensate the increase of radiobiological damage due to hypofractionation for late-reacting tissues.
Böhlen TT; Germond JF; Bourhis J; Bailat C; Bochud F; Moeckli R
Med Phys; 2022 Dec; 49(12):7672-7682. PubMed ID: 35933554
[TBL] [Abstract][Full Text] [Related]
11. Effect of overall time when radiotherapy includes teletherapy and brachytherapy: a mathematical model.
Jones B; Bleasdale C
Br J Radiol; 1994 Jan; 67(793):63-70. PubMed ID: 8298877
[TBL] [Abstract][Full Text] [Related]
12. Optimum overall times II: Extended modelling for head and neck radiotherapy.
Fowler JF
Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):113-26. PubMed ID: 18155893
[TBL] [Abstract][Full Text] [Related]
13. Investigation of various growth mechanisms of solid tumour growth within the linear-quadratic model for radiotherapy.
McAneney H; O'Rourke SF
Phys Med Biol; 2007 Feb; 52(4):1039-54. PubMed ID: 17264369
[TBL] [Abstract][Full Text] [Related]
14. Accelerated repopulation: friend or foe? Exploiting changes in tumor growth characteristics to improve the "efficiency" of radiotherapy.
Marks LB; Dewhirst M
Int J Radiat Oncol Biol Phys; 1991 Oct; 21(5):1377-83. PubMed ID: 1938539
[TBL] [Abstract][Full Text] [Related]
15. A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy.
Hendry JH; Bentzen SM; Dale RG; Fowler JF; Wheldon TE; Jones B; Munro AJ; Slevin NJ; Robertson AG
Clin Oncol (R Coll Radiol); 1996; 8(5):297-307. PubMed ID: 8934049
[TBL] [Abstract][Full Text] [Related]
16. Accelerated repopulation during fractionated irradiation of a murine ovarian carcinoma: downregulation of apoptosis as a possible mechanism.
Thames HD; Ruifrok AC; Milas L; Hunter N; Mason KA; Terry NH; White RA
Int J Radiat Oncol Biol Phys; 1996 Jul; 35(5):951-62. PubMed ID: 8751404
[TBL] [Abstract][Full Text] [Related]
17. How worthwhile are short schedules in radiotherapy? A series of exploratory calculations.
Fowler JF
Radiother Oncol; 1990 Jun; 18(2):165-81. PubMed ID: 2367691
[TBL] [Abstract][Full Text] [Related]
18. Radiobiologically based assessments of the net costs of fractionated focal radiotherapy.
Jones B; Dale RG
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1139-48. PubMed ID: 9719125
[TBL] [Abstract][Full Text] [Related]
19. Is there an optimum overall time for head and neck radiotherapy? A review, with new modelling.
Fowler JF
Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):8-22. PubMed ID: 17305251
[TBL] [Abstract][Full Text] [Related]
20. Utility of normal tissue-to-tumor α/β ratio when evaluating isodoses of isoeffective radiation therapy treatment plans.
Gay HA; Jin JY; Chang AJ; Ten Haken RK
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e81-7. PubMed ID: 23141886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
